MASLD (metabolic dysfunction-associated steatotic liver disease) is what most people know as "fatty liver." It means excess fat has built up in the liver, which over time can cause inflammation, scarring, and serious liver damage
It likely reflect the microbes they have in their gut. But ultimately, he says, while short-term studies looking at the impact of fibers on short chain fatty acid production or the second meal effect* are valuable, the only real test of whether these ingredients amount to Natures Ozempic is looking at clinical endpoints, whether its weight loss, or insulin sensitivity, for example. *the ability of a food to impact consumption at a subsequent meal later in the day or the following day
However, scientists are actively working to solve this problem
Those who use the treatment period strategically have a fighting chance
In clinical trials, hair loss was reported in 3-5% of patients using GLP-1 medications compared to just 1% using placebo
When GLP-1 Medications Are No Longer Working for You By Trace Curry, MD, FASMBS Over the last several years, GLP-1 medications such as semaglutide and tirzepatide have changed the conversation around obesity treatment
